New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake
PM360
JUNE 29, 2022
Among surveyed patients, nearly half (47%) couldn’t remember a single preventive migraine brand name, and the leading brand patients did recall— Topamax —is an older drug that was approved for migraine in 2004. Other influencing factors included more information on side effects (36%), drug cost (28%), and efficacy (28%).
Let's personalize your content